Lazard Asset Management LLC Sarepta Therapeutics, Inc. Transaction History

Lazard Asset Management LLC

$68.3 Billion
Q3 2024

A detailed history of Lazard Asset Management LLC transactions in Sarepta Therapeutics, Inc. stock. As of the latest transaction made, Lazard Asset Management LLC holds 2,273 shares of SRPT stock, worth $285,852. This represents 0.0% of its overall portfolio holdings.

Number of Shares

2,273

Previous 2,836 19.85%

Holding current value

$285,852

Previous $448,000 36.83%

% of portfolio

0.0%

Previous 0.0%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$124.33 - $156.75 $69,997 - $88,250	-563 Reduced 19.85%	2,273 $283,000
Q2 2024 Aug 14, 2024	BUY	$113.33 - $163.85 $33,885 - $48,991	299 Added 11.79%	2,836 $448,000
Q1 2024 May 14, 2024	BUY	$93.7 - $141.53 $14,242 - $21,512	152 Added 6.37%	2,537 $328,000
Q4 2023 Feb 14, 2024	BUY	$67.31 - $124.76 $4,038 - $7,485	60 Added 2.58%	2,385 $229,000
Q3 2023 Nov 14, 2023	BUY	$102.5 - $123.59 $121,975 - $147,072	1,190 Added 104.85%	2,325 $281,000
Q2 2023 Aug 14, 2023	BUY	$106.4 - $157.19 $48,412 - $71,521	455 Added 66.91%	1,135 $129,000
Q1 2023 May 15, 2023	BUY	$117.53 - $155.99 $6,699 - $8,891	57 Added 9.15%	680 $93,000
Q4 2022 Feb 14, 2023	SELL	$100.86 - $132.13 $109,937 - $144,021	-1,090 Reduced 63.63%	623 $80,000
Q3 2022 Nov 14, 2022	BUY	$75.71 - $119.24 $49,135 - $77,386	649 Added 61.0%	1,713 $188,000
Q2 2022 Aug 09, 2022	BUY	$62.69 - $88.44 $2,570 - $3,626	41 Added 4.01%	1,064 $79,000
Q1 2022 May 13, 2022	SELL	$63.15 - $90.42 $26,523 - $37,976	-420 Reduced 29.11%	1,023 $79,000
Q4 2021 Feb 09, 2022	SELL	$77.28 - $99.42 $24,343 - $31,317	-315 Reduced 17.92%	1,443 $129,000
Q3 2021 Nov 15, 2021	SELL	$65.97 - $92.48 $12,204 - $17,108	-185 Reduced 9.52%	1,758 $162,000
Q2 2021 Aug 12, 2021	SELL	$69.38 - $86.75 $316,927 - $396,274	-4,568 Reduced 70.16%	1,943 $150,000
Q1 2021 May 14, 2021	SELL	$72.25 - $168.95 $1.68 Million - $3.92 Million	-23,194 Reduced 78.08%	6,511 $485,000
Q4 2020 Feb 11, 2021	BUY	$125.56 - $178.74 $3.68 Million - $5.24 Million	29,308 Added 7382.37%	29,705 $5.06 Million
Q3 2020 Nov 13, 2020	SELL	$127.12 - $172.34 $19,703 - $26,712	-155 Reduced 28.08%	397 $55,000
Q2 2020 Aug 13, 2020	SELL	$93.0 - $171.7 $52,080 - $96,152	-560 Reduced 50.36%	552 $88,000
Q1 2020 May 14, 2020	BUY	$82.38 - $131.64 $89,629 - $143,224	1,088 Added 4533.33%	1,112 $108,000
Q4 2019 Feb 13, 2020	SELL	$76.53 - $135.58 $11,479 - $20,337	-150 Reduced 86.21%	24 $3,000
Q3 2019 Nov 14, 2019	BUY	$72.81 - $156.91 $12,668 - $27,302	174 New	174 $13,000
Q1 2019 May 13, 2019	SELL	$106.67 - $151.68 $106,670 - $151,680	-1,000 Closed	0 $0
Q3 2018 Nov 13, 2018	SELL	$115.31 - $161.51 $734,524 - $1.03 Million	-6,370 Reduced 86.43%	1,000 $161,000
Q2 2018 Aug 13, 2018	BUY	$71.74 - $153.69 $528,723 - $1.13 Million	7,370 New	7,370 $973,000

Others Institutions Holding SRPT

# of Institutions

530

Shares Held

84.5M

Call Options Held

2.06M

Put Options Held

1.52M

View Full List

About Sarepta Therapeutics, Inc.

Ticker SRPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,567,904
Market Cap $11B
Description
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...

More about SRPT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Lazard Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lazard Asset Management LLC with notifications on news.

Account

Lazard Asset Management LLC Sarepta Therapeutics, Inc. Transaction History